Added to YB: 2021-06-14
Pitch date: 2021-06-14
SNPX [bullish]
Synaptogenix, Inc.
-97.05%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Synaptogenix, Inc. operates as a clinical-stage biopharmaceutical company. It is conducting clinical and preclinical studies of its lead therapeutic candidate, Bryostatin-1, in Alzheimer's disease.
Market Cap
$2.8M
Pitch Price
$203.75
Price Target
N/A
Dividend
N/A
EV/EBITDA
2.03
P/E
-0.18
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
SYNAPTOGENIX INC SNPX
A summary for this pitch has not been created yet.
Read full article (0 min)